Figure 10.
Top 10 enriched compounds that can be used as repurposing drugs against the top 250 co-upregulated genes in RCC according to DrugMatrix (a) and cMap (b,c) databases. The repurposed drugs upregulating or downregulating the co-upregulated genes in RCC, according to Old cMAP analysis are depicted in (b,c), respectively. Asterisks (*) indicate the terms with significant adjusted p-values (<0.05). The scatterplots (right) were created using UMAP and depict clusters of similar compounds. The significantly enriched terms of the associated gene sets are denoted.
